Literature DB >> 15565286

Presenting phenotype in 100 children with the 22q11 deletion syndrome.

Sólveig Oskarsdóttir1, Christina Persson, Bengt O Eriksson, Anders Fasth.   

Abstract

UNLABELLED: The aim of this study was to investigate and describe the presenting phenotype of children with the 22q11 deletion syndrome and to describe common clinical features that could serve as guidelines in the clinical diagnostic process preceding genetic testing. A hospital-based study of 100 consecutive children and adolescents with 22q11 deletion was initiated. The patients were divided into two groups according to age at diagnosis: before or after 2 years of age. Clinical features were grouped into a core set of eight features: cardiac defects, non-visible/hypoplastic thymus or infection problems, hypocalcaemia, feeding difficulties, cleft palate/speech-language impairment, developmental delay/learning difficulties, characteristic dysmorphic features and other malformations and deformities. The median age at diagnosis was 6.7 years. Of all patients, 26% were diagnosed in infancy and 92% had a congenital cardiac defect, whereas 54% of those diagnosed later had a cardiac defect. A cleft palate was present in 25 cases and 44 had some other malformation or deformity. All presented with a combination of many of the core features. Of those diagnosed after 2 years of age, the majority presented with speech-language impairment, developmental delay or learning difficulties and recurrent infections. Characteristic mild dysmorphic features were noticed in all children.
CONCLUSION: In spite of variable clinical expression, children with 22q11 deletion share a number of major features and have a characteristic phenotype. A high proportion have no cardiac defect and hence a risk of diagnostic delay. Increased awareness and knowledge among general paediatricians and other specialists who meet these children early in life is needed to reduce the diagnostic delay.

Entities:  

Mesh:

Year:  2004        PMID: 15565286     DOI: 10.1007/s00431-004-1577-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

Review 1.  Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications.

Authors:  A Swillen; A Vogels; K Devriendt; J P Fryns
Journal:  Am J Med Genet       Date:  2000

Review 2.  Pediatric testicular problems.

Authors:  S B Pillai; G E Besner
Journal:  Pediatr Clin North Am       Date:  1998-08       Impact factor: 3.278

3.  Retrospective analysis of feeding and speech disorders in 50 patients with velo-cardio-facial syndrome.

Authors:  N Rommel; G Vantrappen; A Swillen; K Devriendt; L Feenstra; J P Fryns
Journal:  Genet Couns       Date:  1999

4.  Polymicrogyria in chromosome 22q11 deletion syndrome.

Authors:  Sophie Ghariani; Karin Dahan; Christine Saint-Martin; Hazim Kadhim; Françoise Morsomme; Stéphane Moniotte; Christine Verellen-Dumoulin; Guillaume Sébire
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

5.  Skeletal anomalies and deformities in patients with deletions of 22q11.

Authors:  J E Ming; D M McDonald-McGinn; T E Megerian; D A Driscoll; E R Elias; B M Russell; M Irons; B S Emanuel; R I Markowitz; E H Zackai
Journal:  Am J Med Genet       Date:  1997-10-17

Review 6.  The 22q11.2 deletion syndrome.

Authors:  Hiroyuki Yamagishi
Journal:  Keio J Med       Date:  2002-06

7.  Chromosome 22q11 deletion in patients with ventricular septal defect: frequency and associated cardiovascular anomalies.

Authors:  Doff B McElhinney; Deborah A Driscoll; Elissa R Levin; Abbas F Jawad; Beverly S Emanuel; Elizabeth Goldmuntz
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

8.  Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden.

Authors:  S Oskarsdóttir; M Vujic; A Fasth
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

9.  A prospective cross-sectional study of speech in patients with the 22q11 deletion syndrome.

Authors:  Christina Persson; Anette Lohmander; Radi Jönsson; Sólveig Oskarsdóttir; Ewa Söderpalm
Journal:  J Commun Disord       Date:  2003 Jan-Feb       Impact factor: 2.288

10.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

View more
  43 in total

1.  Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly.

Authors:  Ales Janda; Petr Sedlacek; Manfred Hönig; Wilhelm Friedrich; Martin Champagne; Tadashi Matsumoto; Alain Fischer; Benedicte Neven; Audrey Contet; Danielle Bensoussan; Pierre Bordigoni; David Loeb; William Savage; Nada Jabado; Francisco A Bonilla; Mary A Slatter; E Graham Davies; Andrew R Gennery
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

Review 2.  Clinical genetics in cardiology.

Authors:  Philippe Charron
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

3.  A rare association of interrupted aortic arch type C and microdeletion 22q11.2.

Authors:  Goran Cuturilo; Danijela Drakulic; Milena Stevanovic; Ida Jovanovic; Milan Djukic; Slobodanka Miletic-Grkovic; Marina Atanaskovic-Markovic
Journal:  Eur J Pediatr       Date:  2007-11-27       Impact factor: 3.183

4.  Recognizing a common genetic syndrome: 22q11.2 deletion syndrome.

Authors:  Ronak K Kapadia; Anne S Bassett
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

5.  Premature death in adults with 22q11.2 deletion syndrome.

Authors:  A S Bassett; E W C Chow; J Husted; K A Hodgkinson; E Oechslin; L Harris; C Silversides
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

6.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

7.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

8.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

9.  Models of crk adaptor proteins in cancer.

Authors:  Emily S Bell; Morag Park
Journal:  Genes Cancer       Date:  2012-05

10.  Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report.

Authors:  Karen Zagursky; Ronald A Weller; Naushad Jessani; Jawwad Abbas; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.